Aquestive Therapeutics, Inc. ( AQST) - Key Metrics
AQST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.11 | -$0.18 | -$0.08 | -$0.08 |
| 2026Q1 | $0.12 | -$0.07 | -$0.12 | -$0.12 |
| 2025Q4 | $0.11 | -$0.26 | -$0.07 | -$0.07 |
| 2025Q3 | $0.12 | -$0.14 | -$0.11 | -$0.12 |
| 2025Q2 | $0.10 | -$0.14 | -$0.08 | -$0.08 |
AQST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.78 |
| 2026Q1 | 0% | -14.82 |
| 2025Q4 | 0% | -6.21 |
| 2025Q3 | 0% | -9.98 |
| 2025Q2 | 0% | -5.91 |
AQST
Price: $4.60
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 208846
Market Capitalization: 570.9 million